ruthenium has been researched along with ascorbic acid in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 18 (60.00) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Coty, WA; Pedersen, PL | 1 |
| Hammershøi, A; Nord, G; Rowatt, E; Skov, LK; Williams, RJ | 1 |
| Alessio, E; Iengo, E; Messori, L; Orioli, P; Vullo, D | 1 |
| Alonso, C; Alvarez, Y; Fuertes, MA; González-Vílchez, F; Grguric-Sipka, SR; Pérez, JM; Sabo, TJ; Vilaplana, RA | 1 |
| Cavalheiro, ET; Chierice, GO; Ramos, LA | 1 |
| Bendhack, LM; da Silva, RS; Laurindo, FR; Lima, RG; Lunardi, CN; Rodrigues, GJ; Santos, CX | 1 |
| Bi, S; Niu, Y; Sun, X; Zhang, S | 1 |
| Barbosa, LF; Bertotti, M; Carrì, MT; Medeiros, MH; Paixão, TR | 1 |
| Lam, WW; Lau, KC; Lau, TC; Leung, CF; Man, WL; Wang, YN | 1 |
| Che, CM; Chui, SS; Lau, TC; Ng, MF; Shek, L; Sun, RW; Wong, EL; Zhang, J | 1 |
| Bartel, C; Berger, W; Egger, AE; Galanski, MS; Heffeter, P; Jakupec, MA; Keppler, BK | 1 |
| DeRose, VJ; Hostetter, AA; McFarlane Holman, KL; Miranda, ML | 1 |
| Furrer, J; Paul, LE; Therrien, B | 2 |
| Azuma, H; Kato, N; Nagasaki, T; Ohkanda, J; Yamaguchi, Y | 1 |
| Aleksenko, SS; Foteeva, LS; Jarosz, M; Lu, X; Matczuk, M; Pawlak, K; Timerbaev, AR | 1 |
| Bohn, PW; Contento, NM; Gibson, LR; Ma, C | 1 |
| de Oliveira Silva, D; Santos, RL; van Eldik, R | 1 |
| Cha, A; Jang, HS; Jo, A; Kang, M; Kim, MH; Lee, C; Lee, NS; Lee, Y; Shim, JH | 1 |
| Lam, WW; Lau, TC; Man, WL; Wang, Q | 1 |
| Bergamo, A; Brabec, V; Cocchietto, M; Mestroni, G; Novohradský, V; Sava, G; Zajac, J | 1 |
| Dahlberg, PD; Mulfort, KL; Niklas, J; Poluektov, OG; Soltau, SR; Tiede, DM; Utschig, LM | 1 |
| Cui, L; Liang, X; Liu, H; Liu, W; Xie, J; Yang, J | 1 |
| Ahamad, T; Alshehri, SM; Ataee-Esfahani, H; Henzie, J; Jiang, B; Li, C; Yamauchi, Y | 1 |
| Anderson, RF; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Kim, K; Klapproth, E; Kubanik, M; Roller, A; Söhnel, T | 1 |
| Lee, YG; Liao, BX; Weng, YC | 1 |
| Deng, J; Li, P; Ma, Z; Mei, S; Pan, K | 1 |
| Chen, L; Chen, X; Gong, Y; Lin, A; Liu, J; Liu, Y; Yuan, G; Zhu, X | 1 |
| Dong, Y; Guo, C; Hu, FX; Li, Q; Liu, Y; Lou, F; Rao, Q; Wang, DP; Xie, X; Yang, HB | 1 |
| Ali, A; Chi, H; Hao, H; Liu, Z; Lv, Z; Rahman, FU; Wang, N; Zhang, Y; Zhang, Z; Zhao, X | 1 |
30 other study(ies) available for ruthenium and ascorbic acid
| Article | Year |
|---|---|
Energy-dependent accumulation of calcium and phosphate by purified inner membrane vesicles of rat liver mitochondria.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Ammonia; Aniline Compounds; Animals; Arsenic; Ascorbic Acid; Biological Transport, Active; Calcium; Calcium Isotopes; Chlorides; Coloring Agents; In Vitro Techniques; Liver; Male; Membranes; Mercuribenzoates; Mitochondria, Liver; Organomercury Compounds; Oxides; Phosphates; Phosphorus Isotopes; Rats; Ruthenium; Succinates; Tritium; Uncoupling Agents | 1972 |
The binding of a complex cobalt ruthenium polyamine by deoxyribonucleic acid and a lipopolysaccharide: a model for a novel class of drugs.
Topics: Ascorbic Acid; Cobalt; DNA; Electrochemistry; Escherichia coli; Light; Lipopolysaccharides; Molecular Structure; Polyamines; Ruthenium; Spectrophotometry | 1993 |
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III)anti-neoplastic complex, with bovine serum albumin.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Cattle; Chlorides; Circular Dichroism; Dialysis; Diethyl Pyrocarbonate; Dimethyl Sulfoxide; Histidine; Hydrolysis; Ligands; Organometallic Compounds; Oxidation-Reduction; Protein Binding; Ruthenium; Ruthenium Compounds; Serum Albumin, Bovine; Spectrophotometry, Atomic | 2000 |
Synthesis, characterization, interaction with DNA and cytotoxicity of the new potential antitumour drug cis-K[Ru(eddp)Cl(2)].
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Division; Cell Line, Tumor; Chromatography, Agarose; Circular Dichroism; DNA; Dose-Response Relationship, Drug; HeLa Cells; HT29 Cells; Humans; Hydrolysis; Intercalating Agents; Nucleic Acid Conformation; Organometallic Compounds; Oxidation-Reduction; Plasmids; Ruthenium; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 2003 |
Evaluation of the electrochemical behavior and analytical potentialities of a carbon paste electrode modified with a ruthenium (III) piperidinedithiocarbamate complex.
Topics: Ascorbic Acid; Carbon; Electrochemistry; Electrodes; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Piperidines; Potentiometry; Reproducibility of Results; Ruthenium; Sensitivity and Specificity; Thiocarbamates | 2005 |
Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats.
Topics: Animals; Aorta; Ascorbic Acid; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Hypertension, Renal; Kidney; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Organ Culture Techniques; Organometallic Compounds; Phenylephrine; Rats; Rats, Wistar; Ruthenium; Superoxides; Time Factors; Vasodilation | 2008 |
Determination of ascorbic acid in individual rat hepatocyte cells based on capillary electrophoresis with electrochemiluminescence detection.
Topics: 2,2'-Dipyridyl; Animals; Ascorbic Acid; Electrophoresis, Capillary; Hepatocytes; Luminescent Measurements; Male; Organometallic Compounds; Rats; Ruthenium | 2008 |
Continuous monitoring of ascorbate transport through neuroblastoma cells with a ruthenium oxide hexacyanoferrate modified microelectrode.
Topics: Ascorbic Acid; Biological Transport; Cell Line, Tumor; Electrochemistry; Ferrocyanides; Humans; Microelectrodes; Neuroblastoma; Oxidation-Reduction; Ruthenium | 2008 |
Kinetics and mechanism of the oxidation of ascorbic acid in aqueous solutions by a trans-dioxoruthenium(VI) complex.
Topics: Ascorbic Acid; Hydrogen-Ion Concentration; Kinetics; Organometallic Compounds; Oxidation-Reduction; Ruthenium; Solutions; Spectrophotometry; Stereoisomerism; Thermodynamics; Water | 2009 |
Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands.
Topics: Angiogenesis Inhibitors; Apoptosis; Ascorbic Acid; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Ligands; Molecular Conformation; Pyrazoles; Ruthenium | 2009 |
Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Survival; DNA; Drug Synergism; Drugs, Investigational; Humans; Indazoles; KB Cells; Magnetic Resonance Spectroscopy; Organometallic Compounds; Protein Binding; Reactive Oxygen Species; Ruthenium; Ruthenium Compounds; Tumor Cells, Cultured | 2011 |
Ru binding to RNA following treatment with the antimetastatic prodrug NAMI-A in Saccharomyces cerevisiae and in vitro.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Survival; Dimethyl Sulfoxide; DNA; Hydrogen-Ion Concentration; Hydrolysis; Molecular Structure; Organometallic Compounds; Prodrugs; RNA; Ruthenium; Ruthenium Compounds; Saccharomyces cerevisiae | 2011 |
Investigation of the reactivity between a ruthenium hexacationic prism and biological ligands.
Topics: Amino Acids; Antineoplastic Agents; Arginine; Ascorbic Acid; Cymenes; Cysteine; Disulfides; Glucose; Glutathione; Ligands; Lysine; Magnetic Resonance Spectroscopy; Methionine; Monoterpenes; Organomercury Compounds; Oxidation-Reduction; Ruthenium; Solutions; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2012 |
Protein recognition of hetero-/homoleptic ruthenium(II) tris(bipyridine)s for α-chymotrypsin and cytochrome c.
Topics: 2,2'-Dipyridyl; Apoptosis; Ascorbic Acid; Binding Sites; Cell Line, Tumor; Cell Membrane Permeability; Chymotrypsin; Coordination Complexes; Cytochromes c; Humans; Kinetics; Models, Molecular; Oxidation-Reduction; Potentiometry; Protein Binding; Ruthenium; Thermodynamics | 2012 |
Interaction of a ruthenium hexacationic prism with amino acids and biological ligands: ESI mass spectrometry and NMR characterisation of the reaction products.
Topics: Amino Acids; Ascorbic Acid; Coordination Complexes; Drug Stability; Lactic Acid; Ligands; Magnetic Resonance Spectroscopy; Molecular Structure; Ruthenium; Spectrometry, Mass, Electrospray Ionization | 2012 |
Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(III) drug bound to holo-transferrin in simulated cancer cytosol.
Topics: Antineoplastic Agents; Ascorbic Acid; Blood Proteins; Cell Proliferation; Cytosol; Drug Design; Electrophoresis, Capillary; Glutathione; Humans; Ligands; Mass Spectrometry; Neoplasms; Oxidation-Reduction; Protein Binding; Ruthenium; Time Factors; Transferrin | 2013 |
Recessed ring-disk nanoelectrode arrays integrated in nanofluidic structures for selective electrochemical detection.
Topics: Ascorbic Acid; Dopamine; Electrochemistry; Electrodes; Limit of Detection; Microfluidic Analytical Techniques; Nanotechnology; Ruthenium | 2013 |
Kinetic and mechanistic studies on reactions of diruthenium(II,III) with biologically relevant reducing agents.
Topics: Antineoplastic Agents; Ascorbic Acid; Carboxylic Acids; Glutathione; Kinetics; Reducing Agents; Ruthenium | 2013 |
Nonenzymatic amperometric sensor for ascorbic acid based on hollow gold/ruthenium nanoshells.
Topics: Ascorbic Acid; Carbon; Electrochemical Techniques; Electrodes; Gold; Nanoshells; Particle Size; Porosity; Ruthenium; Surface Properties | 2014 |
Oxidation of ascorbic acid by a (salen)ruthenium(VI) nitrido complex in aqueous solution.
Topics: Ascorbic Acid; Coordination Complexes; Ethylenediamines; Hydrogen-Ion Concentration; Kinetics; Molecular Conformation; Oxidation-Reduction; Ruthenium; Water | 2014 |
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Cell Adhesion; Cell Line, Tumor; Dimethyl Sulfoxide; Humans; Kidney; Liver; Lung; Male; Mice, Inbred ICR; Organometallic Compounds; Oxidation-Reduction; Rhodamines; Ruthenium; Ruthenium Compounds; Serum Albumin | 2015 |
Aqueous light driven hydrogen production by a Ru-ferredoxin-Co biohybrid.
Topics: Ascorbic Acid; Catalysis; Electron Transport; Ferredoxins; Hydrogen; Light; Organometallic Compounds; Photoelectron Spectroscopy; Photosensitizing Agents; Ruthenium | 2015 |
A novel non-enzymatic glucose sensor based on Pt3Ru1 alloy nanoparticles with high density of surface defects.
Topics: Ascorbic Acid; Biosensing Techniques; Carbon; Dielectric Spectroscopy; Electrochemical Techniques; Fructose; Glucose; Limit of Detection; Nanoparticles; Platinum; Ruthenium; Uric Acid | 2016 |
Mesoporous Trimetallic PtPdRu Spheres as Superior Electrocatalysts.
Topics: Ascorbic Acid; Catalysis; Electrochemical Techniques; Methanol; Oxidation-Reduction; Palladium; Particle Size; Platinum; Polyethylenes; Polypropylenes; Porosity; Ruthenium | 2016 |
Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; Drug Resistance, Neoplasm; Glutathione; Humans; Monoterpenes; Naphthoquinones; Ruthenium | 2016 |
Ruthenium oxide modified nickel electrode for ascorbic acid detection.
Topics: Ascorbic Acid; Electrodes; Nickel; Oxidation-Reduction; Oxides; Ruthenium | 2017 |
A One-Pot Polymerization for Concurrently Inducing Predominant Helicity in Optically Inactive Helical Polymer and Constructing Graphene-Based Chiral Hybrid Foams.
Topics: Ascorbic Acid; Catalysis; Graphite; Polymerization; Polymers; Ruthenium; Stereoisomerism | 2019 |
Enzyme-Responsive Mesoporous Ruthenium for Combined Chemo-Photothermal Therapy of Drug-Resistant Bacteria.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Bacterial Infections; Cell Survival; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hyaluronic Acid; Molybdenum; Mutation; Nanoparticles; Prodrugs; Ruthenium | 2019 |
Single-Atom Ruthenium Biomimetic Enzyme for Simultaneous Electrochemical Detection of Dopamine and Uric Acid.
Topics: Ascorbic Acid; Biomimetics; Dopamine; Electrochemical Techniques; Electrodes; Ruthenium; Uric Acid | 2021 |
Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Screening Assays, Antitumor; Ligands; Ruthenium; Signal Transduction | 2023 |